Clinical Trials Directory

Trials / Unknown

UnknownNCT03297840

Change in Mindfulness in Borderline Personality Disorder

Change in Mindfulness in Borderline Personality Disorder After Dialectic-behavioural Therapy (DBT): A Pre-post-comparison

Status
Unknown
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Katharina Bachmann · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The current study aims to investigate the effect of dialectical behavioral therapy on mindfulness in patients with Borderline Personality Disorder. A treatment group will be compared to a waitlist control group.

Detailed description

Participants will be recruited from the Dialectical-Behavioral-Therapy (DBT) unit. DBT is a treatment approach that has been shown to be effective in the treatment of Borderline Personality Disorder. DBT integrates different psychotherapeutic interventions as well as Mindfulness Meditation exercises. Mindfulness is a meditation practice that can improve present moment awareness. When applied as therapeutic intervention mindfulness meditation can help patients to stay with their attention in the present moment, to be aware what is happening in the here and now, and to better identify and regulate upcoming emotions. The current observational study investigates changes in symptom severity and mindfulness skills during DBT treatment. A treatment group will be compared to a waitlist control group. The two groups are predefined by routine medical care. Symptom severity and mindfulness skills will be assessed at baseline (before treatment or when accepted for the waitlist) and after 12-weeks. A within and between group analyses will be performed.

Conditions

Interventions

TypeNameDescription
BEHAVIORALDialectical Behavioural Therapy (DBT)Inpatient Dialectical Behavioural Therapy (DBT) according to Linehan.

Timeline

Start date
2017-05-04
Primary completion
2017-11-01
Completion
2017-12-01
First posted
2017-09-29
Last updated
2017-09-29

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03297840. Inclusion in this directory is not an endorsement.